A miniaturized cardiopulmonary bypass circuit enables the safe performance, in selected pediatric patients, of bloodless open heart surgery. As the latest survival rates in neonatal and infant cardiac surgery have become satisfactory, investigators have concentrated upon the improvement of existing procedures. Institutional guidelines and multidisciplinary efforts undertaken in the pre- and postoperative periods are of great importance, concerning bloodless CPB and should be seriously pursued by all involved caregivers.
This review reflects upon the selective, most relevant requirements for success of asanguinous neonatal and infant CPB: acceptable level of hemodilution during the CPB, patient preoperative hematocrit value and volume of CPB circuit. We present an assessment of practical measures that were also adapted in our institution to achieve an asanguinous CPB for neonatal and infant patients.
Seghaye MC, Grabitz RG, Duchateau J., et al. Inflammatory reaction and capillary leak syndrome related to cardiopulmonary bypass in neonates undergoing cardiac operations. J Thorac Cardiovasc Surg1996 Sep; 112(3): 687-697.
2.
Seghaye MC, Duchateau J., Grabitz RG, et al. Complement activation during cardiopulmonary bypass in infants and children. Relation to postoperative multiple system organ failure. J Thorac Cardiovasc Surg1993 Dec; 106(6): 978-987.
3.
Jansen E., Bengtsson A., Berggren H., Ekroth R., Andreasson S.Clinical variables and pro-inflammatory activation in paediatric heart surgery . Scand Cardiovasc J2001; 35: 201-206.
4.
Tassani P., Schad H., Schreiber C., et al. Extravasation of albumin after cardiopulmonary bypass in newborns . J Cardiothorac Vasc Anesth2007 Apr; 21(2): 174-178.
5.
Brudney CS, Gosling P., Manji M.Pulmonary and renal function following cardiopulmonary bypass is associated with systemic capillary leak. J Cardiothorac Vasc Anesth2005 Apr; 19(2): 188-192.
6.
Hickey E., Karamlou T., You X., et al. The use of a miniaturized circuit and bloodless prime to avoid cerebral no-reflow after neonatal cardiopulmonary bypass. Ann Thorac Surg2007 Mar; 83(3): 895-901.
7.
Karamlou T., Hickey E., Silliman C., Shane I., Ungerleider R.Reducing risk in infant cardiopulmonary bypass: the use of a miniaturized circuit and a crystalloid prime improves cardiopulmonary function and increases cerebral blood flow. Semin Thorac Cardiovasc Surg Pediatr Card Surg Annu2005; 8: 3-11.
8.
Miyaji K., Miyamoto T., Kohira S., et al. Miniaturized cardiopulmonary bypass system in neonates and small children. Interact Cardio Vasc Thorac Surg2008; 7: 75-79.
9.
Draaisa AM, Hazekamp MG, Schoof PH, Hack E., Sturk A., Dion RAE.Phosphorylcholine coating of bypass system used for young infants does not attenuate the inflammatory response. Ann Thorac Surg2006; 81: 1455-1459.
10.
Jensen E., Andreasson S., Bengtsson A., et al. Changes in hemostasis during pediatric heart surgery: impact of biocompatible heparin-coated perfusion system. Ann Thorac Surg2004; 77: 962-967.
11.
Karkouti K. , Beattie WS, Wijeysundera DN, et al. Hemodilution during cardiopulmonary bypass is an independent risk factor for acute renal failure in adult cardiac surgery. J Thorac Cardiovasc Surg2005; 129: 391-400.
12.
Swaminathan M., Philips-Bute BG, Conlon PJ, et al. The association of lowest hematocrit during cardiopulmonary bypass with acute renal injury after coronary artery bypass surgery. Ann Thorac Surg2003; 76: 784-792.
13.
Habib RH, Zacharias A., Schwann TA, Riordan CJ, Durham SJ, Shah A.Adverse effects of low hematocrit during cardiopulmonary bypass in the adult: should current practice be changed?J Thorac Cardiovasc Surg2003; 125: 1438-1450.
14.
Silliman CC , Voelkel NF, Allard JD, et al. Plasma and lipids from stored packed red blood cells cause acute lung injury in an animal model. J Clin Invest1998 Apr 1; 101(7): 1458-1467.
15.
Jacobi KE, Wanke C., Jacobi A., Weisbach V., Hemmerling TMDetermination of eicosanoid and cytokine production in salvage blood, stored red blood cell concentrates, and whole blood. J Clin Anesth2000; 12: 94-99.
16.
Schroeder TH , Hansen M.Effects of fresh versus old stored blood in the priming solution on whole blood lactate levels during paediatric cardiac surgery. Perfusion2005; 20(1): 17-19.
17.
Munoz R., Laussen PC, Palacio G., Zienko L., Piercey G., Wessel DLChanges in whole blood lactate levels during cardiopulmonary bypass for surgery for congenital cardiac disease: an early indicator of morbidity and mortality . J Thorac Cardiovasc Surg2000; 119(1): 155-162.
18.
Hickey E., Karamlou T., You J., Ungerleider RMEffects of circuit miniaturization in reducing inflammatory response to infant cardiopulmonary bypass by elimination of allogeneic blood products . Ann Thorac Surg2006; 81: S2367-72.
19.
Durandy Y.Usefulness of low prime perfusion pediatric circuit in decreasing blood transfusion . ASAIO J2007; 53: 659-661.
20.
Ando M., Takahashi Y., Suzuki N.Open heart surgery for small children without homologous blood transfusion by using remote pump head system. Ann Thorac Surg2004; 78: 1717-1722.
21.
Merkle F., Boettcher W., Schulz F., Koster A., Huebler M., Hetzer R.Perfusion technique for nonhaemic cardiopulmonary bypass prime in neonates and infants under 6 kg body weight. Perfusion2004; 19: 229-237.
22.
Durandy Y.The impact of vacuum-assisted venous drainage and miniaturized bypass circuits on blood transfusion in pediatric cardiac surgery. ASAIO J2009; 55: 117-120.
23.
Ging AL, Onge JR St, Fitzgerald DC, Collazo LR, Bower LS, Shen I.Bloodless cardiac surgery and the pediatric patient: a case study . Perfusion2008; 23, 131-134.
24.
Miyaji K., Kohira S., Miyamoto T., et al. Pediatric cardiac surgery without homologous blood transfusion, using a miniaturized bypass system in infants with lower body weight. J Thorac Cardiovasc Surg2007Aug; 134(2): 284-289.
25.
Kotani Y., Honjo O., Nakakura M., et al. Single center experience with a low volume priming cardiopulmonary bypass circuit for preventing blood transfusion in infants and small children . ASAIO J2009 May/June; 55: 296-299.
26.
Jonas RA, Wypij D., Roth SJ, et al. The influence of hemodilution on outcome after hypothermic cardiopulmonary bypass: results of a randomized trial in infants. J Thorac Cardiovasc Surg2003; 126: 1765-1774.
27.
Newburger JW , Jonas RA, Soul J., et al. Randomized trial of hematocrit 25% versus 35% during hypothermic cardiopulmonary bypass in infant heart surgery . Thorac Cardiovasc Surg2008; 135: 347-354.
28.
Wypij D., Jonas RA, Bellinger DC, et al. The effect of hematocrit during hypothermic cardiopulmonary bypass in infant heart surgery: results from the combined Boston hematocrit trials. J Thorac Cardiovasc Surg2008; 135: 355-360.
29.
Groom RC, Froebe S., Martin J., et al. Update on pediatric perfusion practice in North America: 2005 survey. J Extra Corpor Technol2005; 37: 343-350.
30.
Boettcher W. , Merkel F., Huebler M., et al. Transfusion-free cardiopulmonary bypass in Jehovah’s Witness patients weighing less then 5 kg. J Extracorpor Technol2005; 37: 282-285.
31.
Watanabe Y. , Fuse K., Konishi T.Autologous blood transfusion with recombinant human erythropoietin in heart operations. Ann Thorac Surg1991; 51: 767-772.
32.
Shimpo H., Mizumoto T., Onoda K., Yuasa H., Yada I.Erythropoietin in pediatric cardiac surgery. Chest1997; 111: 1565-1570.
33.
Komai H., Naito Y., Fujiwara H., Suzuki H., Uemura S.Preliminary study of autologous blood predonation in pediatric open heart surgery: impact of advance infusion of recombinant human erythropoietin . Pediatr Cardiol2005; 26: 50-55.
34.
Golab HD, Bogers JJSmall, smaller, smallest. Steps towards bloodless neonatal and infant cardiopulmonary bypass. Perfusion2009; 24: 239-242.
35.
Horisberger J., Jegger D., Boone Y., et al. Impact of a remote pump head on neonatal priming volumes. Perfusion1999; 14: 351-356.
36.
Nakanishi K. , Shichijo T., Shinkawa Y., et al. Usefulness of vacuum-assisted cardiopulmonary bypass circuit for pediatric open-heart surgery in reducing homologous blood transfusion. Eur J Cardiothorac Surg2001; 20: 233-238.
37.
Willcox TWVacuum assisted venous drainage: to air or not to air, that is the question. Has the bubble burst?J Extra Corpor Technol2002; 34: 24-28.
38.
Fiorucci A. , Gerometta PS, DeVecchi M., Guzman C., Costantino ML, Arena V.In vitro assessment of the vacuum-assisted venous drainage (VAVD) system: risks and benefits. Perfusion2004; 19(2): 113-117.
39.
Hudacko A., Sievert A., Sistino J.Gaseous microemboli in a pediatric bypass circuit with an unprimed venous line: an in vitro study. J Extra Corpor Technol2009; 41: 166-171.
40.
Charette K. , Hirata Y., Bograd A., et al. 180 ml and less: cardiopulmonary bypass techniques to minimize hemodilution for neonates and small infants. Perfusion2007; 22: 327-331.
